Sermonix Pharmaceuticals
PrivateLast Round
Strategic
Dec 18, 2023
Total Funding Raised
$107.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sermonix Pharmaceuticals is a biotechnology company that develops and commercializes female-specific oncology products, with a focus on treating ESR1-mutated metastatic breast and gynecological cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sermonix Pharmaceuticals Comparables
Compare Sermonix Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Olema Oncology | 80% | |
| Arvinas Inc | 80% | |
| Kind Pharmaceutical | 80% |
Sermonix Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 18, 2023 | ||||
| Series A Extension | Nov 15, 2021 | ||||
| Series A | Jul 31, 2019 | ||||
| Seed | Oct 31, 2017 | ||||
| Seed | Nov 10, 2016 |
Sermonix Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Perceptive Advisors | Series A Extension |
| Xontogeny | Series A Extension |
| WILD Family Office | Series A |
| HP WILD HOLDING AG | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 38% MoM.
- Dec 18, 2025
Global rights for certain assets acquired by Athira Pharma.
Sermonix Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sermonix Pharmaceuticals's valuation, stock price, and market status.
Is Sermonix Pharma a public or private company?
Sermonix Pharma is a private company.
What is the current stock price of Sermonix Pharma?
Sermonix Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is Sermonix Pharma worth (valuation)?
Valuation information for Sermonix Pharma is not publicly available.
Can I buy Sermonix Pharma stock?
Sermonix Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sermonix Pharma's last funding round?
Sermonix Pharma's most recent funding round was Series A Extension on November 15, 2021.
Who are the main investors in Sermonix Pharma?
Key investors in Sermonix Pharma include Perceptive Advisors, Xontogeny, WILD Family Office, HP WILD HOLDING AG.
Will Sermonix Pharma IPO soon?
No public IPO plans have been announced for Sermonix Pharma.
How can I track Sermonix Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sermonix Pharma's secondary market activity and sign up for updates.